Treatment stratification and prognosis assessment using circulating tumor DNA in locally advanced rectal cancer: A systematic review and meta‐analysis
Abstract Background Circulating tumor DNA (ctDNA) is an emerging biomarker for locally advanced rectal cancer (LARC), giving hope for stratified treatment. As the completed studies have small sample sizes and different experimental methods, systematic review and meta‐analysis were performed to explo...
Main Authors: | Junjie Mi, Rong Wang, Xiaofang Han, Ruijun Ma, Danyu Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-09-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.6434 |
Similar Items
-
Response prediction and risk stratification of patients with rectal cancer after neoadjuvant therapy through an analysis of circulating tumour DNA
by: Wenyang Liu, et al.
Published: (2022-04-01) -
Monitoring of Early Changes of Circulating Tumor DNA in the Plasma of Rectal Cancer Patients Receiving Neoadjuvant Concomitant Chemoradiotherapy: Evaluation for Prognosis and Prediction of Therapeutic Response
by: Filip Pazdirek, et al.
Published: (2020-07-01) -
Assessment of circulating tumor DNA in patients with locally advanced rectal cancer treated with neoadjuvant therapy
by: Chiara Molinari, et al.
Published: (2024-11-01) -
Is clinical complete response as accurate as pathological complete response in patients with mid-low locally advanced rectal cancer?
by: Niyaz Shadmanov, et al.
Published: (2025-02-01) -
Impact of Sarcopenia on Treatment Outcomes and Toxicity in Locally Advanced Rectal Cancer
by: Sebastian Curcean, et al.
Published: (2024-10-01)